Nasolacrimal duct obstruction secondary to lacrimal sac involvement by sebaceous carcinoma.
Adenocarcinoma, Sebaceous
/ complications
Antibiotics, Antineoplastic
/ therapeutic use
Dacryocystorhinostomy
Eye Neoplasms
/ complications
Female
Humans
Lacrimal Apparatus Diseases
/ complications
Lacrimal Duct Obstruction
/ etiology
Middle Aged
Mitomycin
/ therapeutic use
Nasolacrimal Duct
/ pathology
Natural Orifice Endoscopic Surgery
Sebaceous Gland Neoplasms
/ complications
Eyelid
lacrimal
nasolacrimal
ocular
sebaceous carcinoma
Journal
Orbit (Amsterdam, Netherlands)
ISSN: 1744-5108
Titre abrégé: Orbit
Pays: England
ID NLM: 8301221
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
pubmed:
7
12
2019
medline:
10
7
2021
entrez:
7
12
2019
Statut:
ppublish
Résumé
Sebaceous carcinoma (SC) is the third most common eyelid malignancy in Australia, and is potentially fatal. It usually presents as a nodule or diffuse eyelid thickening, and is commonly misdiagnosed. We describe a case of SC with lacrimal sac involvement, presenting with clinical features of nasolacrimal duct obstruction. At the time of endoscopic dacryocystorhinostomy (DCR), nasal endoscopy revealed a polypoid mass of the opened lacrimal sac. Biopsy of the mass showed poorly differentiated SC. The lacrimal drainage apparatus was later excised via a combined external and endoscopic approach. Conjunctival map biopsies showed extensive intraepithelial disease, which was treated with topical mitomycin C. At three-month follow-up, there was no evidence of residual disease on nasal endoscopy or repeat conjunctival biopsy.
Identifiants
pubmed: 31809621
doi: 10.1080/01676830.2019.1700282
doi:
Substances chimiques
Antibiotics, Antineoplastic
0
Mitomycin
50SG953SK6
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM